One of the most closely-watched vacancies in biopharma has

Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader Ugur Sahin prepares to join a fledgling mRNA startup.

One of the most closely-watched vacancies in biopharma has